Compare Bundamedik Tbk (BMHS) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 93.5K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp130 (market cap 170.67B, 1.08M 24h volume). The key difference: Bundamedik Tbk is far larger — about 8.8× Zyrexindo Mandiri Buana Tbk.'s market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (1.08M versus 93.5K). Which is the better fit depends on your goals.
| BMHS | ZYRX | |
|---|---|---|
Market Cap | 1.51T | 170.67B |
Volume | 93.5K | 1.08M |
Lot | 935 | 10.83K |
Turnover | 16.49M | 139.75M |
Average Price | 176.32 | 128.99 |
Value | 16.49M | 139.75M |
Indicative Equilibrium Price | 177 | 124 |
Indicative Equilibrium Volume | 108 | 51 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
